How many puffs are in the inhaler?

Official answer

by Drugs.com

Key Points

Bevespi Aerosphere aerosol inhaler contains either 120 or 28 inhalations depending up the size of the inhaler you receive. There is a dose indicator display window on the inhaler which indicates how many inhalations remain. When the dose indicator window shows zero, Bevespi Aerosphere should be thrown away, even though the canister may not feel empty.

The dose indicator display will move after every 10 uses. Discard the 120 count canister 3 months after removal from the foil pouch. For the canister that contains 28 inhalations, discard it 3 weeks after removal from the pouch.

Bevespi Aerosphere (formoterol and glycopyrrolate) inhaler comes in two sizes: either 120 inhalations per canister (weight of 10.7 grams) or 28 inhalations per canister (weight of 5.9 grams). Your doctor may give you the smaller size as a free sample when you are first starting treatment to see how you respond.

What is in Bevespi Aerosphere?

Bevespi Aerosphere is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD) in adult patients.

COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both.

Bevespi Aerosphere is used as a long-term maintenance treatment to improve breathing symptoms of COPD.

This medicine combines an anticholinergic known as glycopyrrolate and a long-acting beta2-adrenergic agonist (LABA) medicine called formoterol fumarate.

Bevespi Aerosphere is not used to treat sudden breathing symptoms of COPD or for treatment of asthma. Always have a rescue inhaler (an inhaled, short-acting bronchodilator like albuterol) with you to treat sudden symptoms. If you do not have a rescue inhaler, contact your doctor to have one prescribed for you.

How long will my Bevespi Aerosphere inhaler last?

The recommended dose for Bevespi Aerosphere is 2 inhalations twice per day (in the morning and in the evening). Use it twice per day every day. Your canister will last 30 days (with the 120 count inhaler) or 7 days (with the 28 count inhaler). The metered dose inhaler delivers 9 mcg of glycopyrrolate and 4.8 mcg of formoterol fumarate per puff.

Read the step-by-step instructions for using Bevespi Aerosphere inhaler found at the end of the Patient Information. Ask your doctor or pharmacist if you do not understand these instructions. Only use your inhaler as your doctor prescribes.

Bottom Line

Bevespi Aerosphere aerosol inhaler contains either 120 or 28 inhalations (puffs) depending up the size of the inhaler you receive. Follow only your doctor's dosing directions.

The usual dose for Bevespi Aerosphere is 2 inhalations twice per day (in the morning and in the evening). Your canister will last 30 days (with the 120 count inhaler) or 7 days (with the 28 count inhaler). The dose display window on the inhaler indicates how many inhalations you have left.

When the dose indicator window shows zero, the Bevespi Aerosphere canister should be thrown away, even though it may not feel empty. Contact your doctor for a refill if you do not have one, or ask the pharmacist to call.

This is not all the information you need to know about Bevespi Aerosphere for safe and effective use. Review the full Bevespi Aerosphere information here, and discuss this and any questions you have with your doctor or other health care provider.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.